Department of Dermatology, Kyorin University School of Medicine, Tokyo, Japan.
Clin Exp Dermatol. 2010 Dec;35(8):863-8. doi: 10.1111/j.1365-2230.2010.03820.x.
Similar drugs (e.g. anticonvulsants) have been implicated in the development of two distinct forms of severe cutaneous drug reactions, Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) and drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS).
To investigate immunological alterations and underlying viral infections that could contribute to the variability in the clinical presentations of these diseases.
We retrospectively analysed clinical variables, serum immunoglobulin levels, numbers of circulating white blood cells, lymphocytes and their subsets, serum levels of several cytokines, and underlying viral infections in both drug reactions, using samples obtained at onset from 9 patients with SJS/TEN and 19 patients with DIHS/DRESS.
There were significant differences between the two drug eruptions in the duration of drug intake before onset, the levels of IgG, IgA and IgM, the numbers of circulating white blood cell, lymphocyte, CD3+ T cell and CD8+ T cells, the serum levels of interferon-γ, and the titres of anti-herpes simplex virus IgG at onset.
The difference in the pattern of immune responses shaped in part by previous and underlying viral infections at the time of drug exposure could cause a marked deviation in the pathological phenotype of severe drug eruptions. Elucidating these host factors may provide a basis for therapeutic approaches in patients with severe drug reactions.
相似的药物(如抗惊厥药)已被牵连到两种不同形式的严重皮肤药物反应,史蒂文斯-约翰逊综合征(SJS)/中毒性表皮坏死松解症(TEN)和药物诱导的超敏反应综合征(DIHS)/药物疹伴嗜酸性粒细胞增多和全身症状(DRESS)的发展中。
研究免疫改变和潜在的病毒感染,这些因素可能导致这些疾病临床表现的差异。
我们回顾性分析了 9 例 SJS/TEN 和 19 例 DIHS/DRESS 患者发病时的临床变量、血清免疫球蛋白水平、循环白细胞、淋巴细胞及其亚群数量、几种细胞因子的血清水平以及潜在的病毒感染。
两种药物反应在发病前药物摄入的持续时间、IgG、IgA 和 IgM 水平、循环白细胞、淋巴细胞、CD3+T 细胞和 CD8+T 细胞数量、干扰素-γ的血清水平以及抗单纯疱疹病毒 IgG 的滴度方面存在显著差异。
免疫反应模式的差异部分由药物暴露时先前和潜在的病毒感染形成,可能导致严重药物反应的病理表型明显偏离。阐明这些宿主因素可能为严重药物反应患者的治疗方法提供依据。